| Francesco Giorgino S Perrini, L Laviola, MC Carreira, A Cignarelli, A Natalicchio Journal of Endocrinology 205, 201-10, 2010 | 462 | 2010 |
| The role of oxidative stress in cardiac disease: from physiological response to injury factor R D’Oria, R Schipani, A Leonardini, A Natalicchio, S Perrini, A Cignarelli, ... Oxidative medicine and cellular longevity 2020 (1), 5732956, 2020 | 339 | 2020 |
| Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis M Castellana, E Conte, A Cignarelli, S Perrini, A Giustina, L Giovanella, ... Reviews in Endocrine and Metabolic Disorders 21 (1), 5-16, 2020 | 247 | 2020 |
| Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) M Caprio, M Infante, E Moriconi, A Armani, A Fabbri, G Mantovani, ... Journal of endocrinological investigation 42, 1365-1386, 2019 | 241 | 2019 |
| Insulin and insulin receptors in adipose tissue development A Cignarelli, VA Genchi, S Perrini, A Natalicchio, L Laviola, F Giorgino International journal of molecular sciences 20 (3), 759, 2019 | 230 | 2019 |
| Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells S Perrini, L Laviola, A Cignarelli, M Melchiorre, F De Stefano, ... Diabetologia 51, 155-164, 2008 | 163 | 2008 |
| Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane S Perrini, A Natalicchio, L Laviola, G Belsanti, C Montrone, A Cignarelli, ... Diabetes 53 (1), 41-52, 2004 | 139 | 2004 |
| The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion A Natalicchio, N Marrano, G Biondi, R Spagnuolo, R Labarbuta, I Porreca, ... Diabetes 66 (11), 2849-2856, 2017 | 127 | 2017 |
| Insulin signaling in human visceral and subcutaneous adipose tissue in vivo L Laviola, S Perrini, A Cignarelli, A Natalicchio, A Leonardini, ... Diabetes 55 (4), 952-961, 2006 | 121 | 2006 |
| Diabetes and cancer: Pathophysiological fundamentals of a ‘dangerous affair’ A Cignarelli, VA Genchi, I Caruso, A Natalicchio, S Perrini, L Laviola, ... Diabetes research and clinical practice 143, 378-388, 2018 | 100 | 2018 |
| GLP‐1 receptor agonist added to insulin versus basal‐plus or basal‐bolus insulin therapy in type 2 diabetes: a systematic review and meta‐analysis M Castellana, A Cignarelli, F Brescia, L Laviola, F Giorgino Diabetes/metabolism research and reviews 35 (1), e3082, 2019 | 99 | 2019 |
| Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) M Bonomi, V Vezzoli, C Krausz, F Guizzardi, S Vezzani, M Simoni, I Bassi, ... European journal of endocrinology 178 (1), 23-32, 2018 | 97 | 2018 |
| Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis M Castellana, C Parisi, S Di Molfetta, L Di Gioia, A Natalicchio, S Perrini, ... BMJ Open Diabetes Research and Care 8 (1), e001092, 2020 | 90 | 2020 |
| Influence of CAG repeat polymorphism on the targets of testosterone action G Tirabassi, A Cignarelli, S Perrini, N Delli Muti, G Furlani, M Gallo, ... International journal of endocrinology 2015 (1), 298107, 2015 | 87 | 2015 |
| Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-α (TNFα) and inhibits TNFα-induced apoptosis in insulin-secreting cells A Natalicchio, F De Stefano, MR Orlando, M Melchiorre, A Leonardini, ... Endocrinology 151 (5), 2019-2029, 2010 | 85 | 2010 |
| Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway A Natalicchio, R Labarbuta, F Tortosa, G Biondi, N Marrano, ... Diabetologia 56, 2456-2466, 2013 | 80 | 2013 |
| Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: a meta-analysis M Castellana, A Cignarelli, F Brescia, S Perrini, A Natalicchio, L Laviola, ... Scientific reports 9 (1), 1-8, 2019 | 72 | 2019 |
| Adipose tissue dysfunction and obesity-related male hypogonadism VA Genchi, E Rossi, C Lauriola, R D’Oria, G Palma, A Borrelli, ... International Journal of Molecular Sciences 23 (15), 8194, 2022 | 71 | 2022 |
| Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and … S Perrini, R Ficarella, E Picardi, A Cignarelli, M Barbaro, P Nigro, ... PloS one 8 (3), e57892, 2013 | 68 | 2013 |
| Cardiovascular and renal effectiveness of GLP-1 receptor agonists vs. other glucose-lowering drugs in type 2 diabetes: a systematic review and meta-analysis of real-world studies I Caruso, A Cignarelli, GP Sorice, A Natalicchio, S Perrini, L Laviola, ... Metabolites 12 (2), 183, 2022 | 67 | 2022 |
Francesco GiorginoUniversity of Bari Aldo MoroAdresse e-mail validée de uniba.it